J. KALDEN

Publication List Details

Period

2008 - 2008

Number

33

Co-Authors

Hollow zinc oxide mesocrystals from an ionic liquid precursor (ILP) (2008)

Li, Z.H., Gessner, A., Richters, J.P., Kalden, J., Voss, T., Kübel, C., ...

The highly hydrated ionic liquid tetrabutylammonium hydroxide (TBAH) is an efficient ionic liquid precursor (ILP) for the fabrication of zinc oxide mesocrystals. Upon reaction of TBAH with zinc...

Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

Scott, D, Smolen, J, Kalden, J, Larsen, A, Kvien, T, ...

OBJECTIVE—Recent studies have demonstrated the short term efficacy of leflunomide. This study evaluates the efficacy and safety of leflunomide and sulfasalazine in rheumatoid arthritis over a two...

Autoantibody profiles in the sera of European patients with myositis

Brouwer, R, Hengstman, G, Egberts, W, Ehrfeld, H, Bozic, B, Ghirardello, A, ...

OBJECTIVE—To determine the prevalence of myositis specific autoantibodies (MSAs) and several myositis associated autoantibodies (MAAs) in a large group of patients with myositis.
METHODS—A...

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

Manger, K, Manger, B, Repp, R, Geisselbrecht, M, Geiger, A, Pfahlberg, A, ...

Background: The survival rate in patients with systemic lupus erythematosus (SLE) has improved dramatically during the past four decades to 96.6% (five year) in the Erlangen cohort, but it is nearly...

Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

Emery, P, Breedveld, F, Dougados, M, Kalden, J, Schiff, M, Smolen, J

Objective: To develop a referral recommendation that may serve as a clinical guide for primary care doctors, enabling them to identify patients with suspected RA during the early inflammatory stages.

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study

Tzioufas, A, Wassmuth, R, Dafni, U, Guialis, A, Haga, H, Isenberg, D, ...

Objectives: To investigate the clinical and immunogenetic aspects of antibody formation against Ro/SSA and La/SSB as well as their linear B cell epitopes in patients with primary Sjögren's syndrome...

Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms

Manger, K, Repp, R, Jansen, M, Geisselbrecht, M, Wassmuth, R, Westerdaal, N, ...

Background: Receptors for IgG play an important part in immune complex clearance. Several studies have identified polymorphisms of receptors for the Fc fragment of IgG (FcγR) as genetic factors...

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

Rau, R, Breedveld, F, Kalden, J, Malaise, M, ...

Objectives: To evaluate efficacy, dose response, safety, and tolerability of adalimumab (D2E7) in disease modifying antirheumatic drug (DMARD) refractory patients with longstanding, active rheumatoid...

Factors associated with coronary artery calcification in young female patients with SLE

Manger, K, Kusus, M, Forster, C, Ropers, D, Daniel, W, Kalden, J, ...

Background: With improved survival rates of patients with systemic lupus erythematosus (SLE), damage such as accelerated atherosclerosis gains increasing importance.

Infliximab in active early rheumatoid arthritis

Breedveld, F, Emery, P, Keystone, E, Patel, K, Furst, D, Kalden, J, ...

Objective: To examine the impact of the combination of infliximab plus methotrexate (MTX) on the progression of structural damage in patients with early rheumatoid arthritis (RA).

Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences

Kraetsch, H, Antoni, C, Kalden, J, Manger, B

OBJECTIVE—To test the efficacy of infliximab in the treatment of patients with severe and active adult onset Still's syndrome (AOSD) despite conventional immunosuppressive therapy.
PATIENTS AND...

Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years

Kalden, J, Scott, D, Smolen, J, Strand, V

Methods: Patients treated with leflunomide for >2 years in one of three phase III trials and subsequent extensions, for whom paired, evaluable radiographs at baseline and study end point were...

The suppression of experimental thyroiditis in the rat by heterologous anti-lymphocyte globulin

Kalden, J., James, K., Williamson, W. G., Irvine, W. J.

The auto-allergic thyroiditis produced in rats by the injection of rat thyroglobulin in complete Freund's adjuvant can be suppressed by the administration of the IgG immunoglobulin fraction of...

The effect of anti-lymphocytic IgG on established autoallergic thyroiditis in rats

Kalden, J., James, K., Williamson, W. G., Irvine, W. J.

The autoallergic thyroiditis produced in rats by the injection of rat thyroglobulin in Freund's complete adjuvant can be suppressed by the administration of the IgG immunoglobulin fraction of...

Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis

Gabler, C, Blank, N, Hieronymus, T, Schiller, M, Berden, J, Kalden, J, ...

Objective: To evaluate the presence of histones and nucleosomes in cell lysates of freshly isolated peripheral blood mononuclear cells (PBMC), fully activated lymphoblasts, or lymphoblasts after...

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

Calin, A, Dijkmans, B, Emery, P, Hakala, M, Kalden, J, Leirisalo-Repo, M, ...

Objective: A double blind, randomised, placebo controlled study to evaluate the safety and efficacy of etanercept to treat adult patients with ankylosing spondylitis (AS).